Global Hydroxychloroquine Market Report By Disease Indication (Malaria, Coronavirus disease (COVID 19), Lupus ErythematosusAnd Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11211921
April 2020
Report Formats:

The global demand for Hydroxychloroquine Market is presumed to reach the valuation of nearly USD 3963.5MN by 2026 from USD 485MN in 2019 with a CAGR of 35% under the study period of 2020 - 2026.
 
Hydroxychloroquine is a quinoline medicine utilized to treat or prevent malaria. Malaria is common disease in few countries such as Africa, South America, and Southern Asia. As this medicine is not operative against all strains of malaria. Hydroxychloroquine is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Its alternative name is Hydroxychloroquine sulfate and it is sold in the brand name of Plaquenil, Hydroquin, Axemal (in India), Dolquine, Quensyl and Quinoric.
 
Market Dynamics
 
The market is primarily driven by rising occurrences of chronic diseases globally as hydroxychloroquine is used in treatment of number of diseases such as uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, and systemic lupus erythematosus as it is commonly prescribed for these diseases which makes this market steady as number of cases on diseases such as malaria is high every year.For instance, according to WHO (World Health Organization) in 2018, an estimated 228 million cases of malaria happened worldwide compared with 231 million cases in 2017. From this it is also estimated that, there is a constant need of Hydroxychloroquine in treating this disease making the market less vulnerable to outside changes. Recent positive research on treatment of novel coronavirus using Hydroxychloroquine came up with positive signs, which is helping in growing demand of this drug from last one month. However, the drug has some serious side effects which restrains the market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of hydroxychloroquine.
 
Market Segmentation
 
The entire hydroxychloroquine market has been sub-categorized into disease indication and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Disease Indication

  • Malaria
  • Coronavirus disease (COVID 19)
  • Lupus Erythematosus
  • Rheumatoid Arthritis
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for hydroxychloroquine market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Hydroxychloroquine Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the hydroxychloroquine market include Sanofi S.A., Amneal Pharmaceuticals, Inc., Laurus Labs Limited, Zydus Pharmaceuticals, Inc., Prasco Laboratories, Dr. Reddy's Laboratories, Cadila Pharmaceuticals, Novartis International AG, Concordia Pharmaceuticals Inc., Covis Pharmaceuticals, Inc., Cardinal Health, AphenaPharma Solutions Tennessee, Inc., Mylan N.V., McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin Pharmaceutical, and Sun Pharmaceutical Industries Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Hydroxychloroquine Market
       2.2. Global Hydroxychloroquine Market Snapshot
 
3 . HYDROXYCHLOROQUINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Hydroxychloroquine Market
       3.3. Market Restraints of Hydroxychloroquine Market
       3.4. Opportunities of Hydroxychloroquine Market
       3.5. Trends of Hydroxychloroquine Market
       3.6. Porter’s Five Force Analysis of Hydroxychloroquine Market
       3.7. Hydroxychloroquine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Disease Indication
           3.7.2 Market Attractive Analysis by Distribution Channel
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Hydroxychloroquine Value Chain Analysis
       4.2. Hydroxychloroquine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Hydroxychloroquine Raw Material Manufactures List
           4.2.3. Price Trend of Hydroxychloroquine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL HYDROXYCHLOROQUINE MARKET ANALYSIS BY DISEASE INDICATION
       5.1 Overview by Disease Indication
       5.2 Global Hydroxychloroquine Market Analysis by Disease Indication
       5.3 Market Analysis of Malaria by Regions
       5.4 Market Analysis of Coronavirus disease (COVID 19) by Regions
       5.5 Market Analysis of Lupus Erythematosus by Regions
       5.6 Market Analysis of Rheumatoid Arthritis by Regions
 
6 . GLOBAL HYDROXYCHLOROQUINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       6.1 Overview by Distribution Channel
       6.2 Global Hydroxychloroquine Market Analysis by Distribution Channel
       6.3 Market Analysis of Hospital Pharmacies by Regions
       6.4 Market Analysis of Retail Pharmacies by Regions
       6.5 Market Analysis of Online Pharmacies by Regions
 
7 . GLOBAL HYDROXYCHLOROQUINE MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Hydroxychloroquine Market Estimate by Market Segment
           7.3.3. North America Hydroxychloroquine Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Hydroxychloroquine Market Estimate by Market Segment
           7.4.3. Europe Hydroxychloroquine Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Hydroxychloroquine Market Estimate by Market Segment
           7.5.3. Asia Pacific Hydroxychloroquine Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Hydroxychloroquine Market Estimate by Market Segment
           7.6.3. Latin America Hydroxychloroquine Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Hydroxychloroquine Market Estimate by Market Segment
           7.7.3. Middle East & Africa Hydroxychloroquine Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE HYDROXYCHLOROQUINE COMPANIES
       8.1. Hydroxychloroquine Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF HYDROXYCHLOROQUINE INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Sanofi S.A.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Amneal Pharmaceuticals, Inc.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Laurus Labs Limited
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Zydus Pharmaceuticals, Inc.
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Prasco Laboratories
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Dr. Reddy's Laboratories
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Cadila Pharmaceuticals
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Novartis International AG
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Concordia Pharmaceuticals Inc.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments
       9.12. Covis Pharmaceuticals, Inc.
           9.12.1. Company Overview
           9.12.2. Financials
           9.12.3. Products
           9.12.4. Recent Developments
       9.13. Cardinal Health
           9.13.1. Company Overview
           9.13.2. Financials
           9.13.3. Products
           9.13.4. Recent Developments
       9.14. AphenaPharma Solutions Tennessee, Inc.
           9.14.1. Company Overview
           9.14.2. Financials
           9.14.3. Products
           9.14.4. Recent Developments
       9.15. Mylan N.V.
           9.15.1. Company Overview
           9.15.2. Financials
           9.15.3. Products
           9.15.4. Recent Developments
       9.16. McKesson Corporation
           9.16.1. Company Overview
           9.16.2. Financials
           9.16.3. Products
           9.16.4. Recent Developments
       9.17. Teva Pharmaceutical Industries Ltd.
           9.17.1. Company Overview
           9.17.2. Financials
           9.17.3. Products
           9.17.4. Recent Developments
       9.18. Lupin Pharmaceutical
           9.18.1. Company Overview
           9.18.2. Financials
           9.18.3. Products
           9.18.4. Recent Developments
       9.19. Sun Pharmaceutical Industries Ltd.
           9.19.1. Company Overview
           9.19.2. Financials
           9.19.3. Products
           9.19.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Hydroxychloroquine Market Snapshot
  • Drivers of The Global Hydroxychloroquine Market Impact Analysis
  • Restraints of The Global Hydroxychloroquine Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Global Hydroxychloroquine Market Analysis in Malaria by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Coronavirus disease (COVID 19) by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Lupus Erythematosus by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Rheumatoid Arthritis by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis by Distribution Channel (USD MN)
  • Global Hydroxychloroquine Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Hydroxychloroquine Market by Geography (USD MN)
  • North America Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • North America Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • North America Hydroxychloroquine Market Estimate by Country (USD MN)
  • United State Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • United State Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Rest of North America Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Rest of North America Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Europe Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Europe Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • United Kingdom Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • France Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • France Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Germany Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Germany Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Rest of Europe Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Asia Pacific Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Hydroxychloroquine Market Estimate by Country (USD MN)
  • China Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • China Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Japan Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Japan Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • India Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • India Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Rest of Asia Pacific Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Latin America Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Latin America Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Latin America Hydroxychloroquine Market Estimate by Country (USD MN)
  • Brazil Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Brazil Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Rest of Latin America Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Middle East & Africa Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Hydroxychloroquine Market Estimate by Country (USD MN)
  • Middle East Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Middle East Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Africa Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Africa Hydroxychloroquine Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Hydroxychloroquine Report
  • Market Research Process
  • Market Research Methodology
  • Global Hydroxychloroquine Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Disease Indication
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Hydroxychloroquine Market Analysis by Disease Indication (USD MN)
  • Global Hydroxychloroquine Market Analysis in Malaria by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Coronavirus disease (COVID 19) by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Lupus Erythematosus by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Rheumatoid Arthritis by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis by Distribution Channel (USD MN)
  • Global Hydroxychloroquine Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Hydroxychloroquine Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Hydroxychloroquine Market by Revenue
  • Middle East & Africa Hydroxychloroquine Market by Revenue
  • Recent Development in Hydroxychloroquine Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials